vs
Side-by-side financial comparison of Pulmonx Corp (LUNG) and Maison Solutions Inc. (MSS). Click either name above to swap in a different company.
Maison Solutions Inc. is the larger business by last-quarter revenue ($27.6M vs $20.6M, roughly 1.3× Pulmonx Corp). Maison Solutions Inc. runs the higher net margin — -18.0% vs -66.3%, a 48.3% gap on every dollar of revenue. On growth, Pulmonx Corp posted the faster year-over-year revenue change (-8.7% vs -10.9%). Over the past eight quarters, Maison Solutions Inc.'s revenue compounded faster (42.5% CAGR vs -0.5%).
Pulmonx Corp is a global medical tech firm focused on interventional pulmonology solutions. It develops minimally invasive endobronchial valves to treat severe COPD and emphysema, with products sold across North America, Europe, and Asia-Pacific for patients with advanced lung conditions.
Maison Solutions Inc.MSSEarnings & Financial Report
Maison Solutions Inc. is a specialty home goods retail company that provides a diverse portfolio of stylish, affordably priced furniture, home decor items, and daily household products. Its primary market is the Guangdong-Hong Kong-Macao Greater Bay Area in China, serving mass consumers through both offline physical stores and online e-commerce channels.
LUNG vs MSS — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $20.6M | $27.6M |
| Net Profit | $-13.7M | $-5.0M |
| Gross Margin | 77.9% | 23.4% |
| Operating Margin | -40.9% | -4.9% |
| Net Margin | -66.3% | -18.0% |
| Revenue YoY | -8.7% | -10.9% |
| Net Profit YoY | 5.5% | -1840.5% |
| EPS (diluted) | $-0.33 | $-0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $20.6M | — | ||
| Q4 25 | $22.6M | $27.6M | ||
| Q3 25 | $21.5M | $27.2M | ||
| Q2 25 | $23.9M | $34.4M | ||
| Q1 25 | $22.5M | $32.3M | ||
| Q4 24 | $23.8M | $29.4M | ||
| Q3 24 | $20.4M | $28.2M | ||
| Q2 24 | $20.8M | $16.9M |
| Q1 26 | $-13.7M | — | ||
| Q4 25 | $-10.4M | $-5.0M | ||
| Q3 25 | $-14.0M | $-1.5M | ||
| Q2 25 | $-15.2M | $-287.4K | ||
| Q1 25 | $-14.4M | $1.0M | ||
| Q4 24 | $-13.2M | $-256.0K | ||
| Q3 24 | $-14.1M | $700.9K | ||
| Q2 24 | $-15.3M | $-2.8M |
| Q1 26 | 77.9% | — | ||
| Q4 25 | 77.6% | 23.4% | ||
| Q3 25 | 74.7% | 24.1% | ||
| Q2 25 | 72.1% | 9.5% | ||
| Q1 25 | 72.5% | 21.8% | ||
| Q4 24 | 74.0% | 26.9% | ||
| Q3 24 | 73.7% | 28.9% | ||
| Q2 24 | 73.7% | 13.0% |
| Q1 26 | -40.9% | — | ||
| Q4 25 | -43.8% | -4.9% | ||
| Q3 25 | -66.9% | 0.7% | ||
| Q2 25 | -62.0% | -15.9% | ||
| Q1 25 | -64.6% | 3.7% | ||
| Q4 24 | -56.5% | 3.2% | ||
| Q3 24 | -69.3% | 7.3% | ||
| Q2 24 | -75.2% | -14.4% |
| Q1 26 | -66.3% | — | ||
| Q4 25 | -46.1% | -18.0% | ||
| Q3 25 | -64.9% | -5.7% | ||
| Q2 25 | -63.6% | -0.8% | ||
| Q1 25 | -64.1% | 3.1% | ||
| Q4 24 | -55.4% | -0.9% | ||
| Q3 24 | -69.4% | 2.5% | ||
| Q2 24 | -73.7% | -16.4% |
| Q1 26 | $-0.33 | — | ||
| Q4 25 | $-0.25 | $-0.23 | ||
| Q3 25 | $-0.34 | $-0.08 | ||
| Q2 25 | $-0.38 | $-0.02 | ||
| Q1 25 | $-0.36 | $0.06 | ||
| Q4 24 | $-0.33 | $-0.01 | ||
| Q3 24 | $-0.36 | $0.04 | ||
| Q2 24 | $-0.39 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $61.6M | — |
| Total DebtLower is stronger | $37.3M | $2.6M |
| Stockholders' EquityBook value | $45.8M | $11.6M |
| Total Assets | $120.0M | $75.4M |
| Debt / EquityLower = less leverage | 0.82× | 0.22× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.6M | — | ||
| Q4 25 | $69.8M | — | ||
| Q3 25 | $76.5M | $1.1M | ||
| Q2 25 | $75.5M | $775.4K | ||
| Q1 25 | $74.6M | $445.4K | ||
| Q4 24 | $70.9M | $355.7K | ||
| Q3 24 | $63.3M | $588.9K | ||
| Q2 24 | $63.5M | $2.1M |
| Q1 26 | $37.3M | — | ||
| Q4 25 | $37.1M | $2.6M | ||
| Q3 25 | $37.1M | $2.6M | ||
| Q2 25 | $37.1M | $2.6M | ||
| Q1 25 | $37.2M | — | ||
| Q4 24 | $37.2M | — | ||
| Q3 24 | $37.2M | $2.5M | ||
| Q2 24 | $37.2M | $2.6M |
| Q1 26 | $45.8M | — | ||
| Q4 25 | $54.1M | $11.6M | ||
| Q3 25 | $60.0M | $10.1M | ||
| Q2 25 | $69.1M | $11.7M | ||
| Q1 25 | $77.7M | $12.0M | ||
| Q4 24 | $85.8M | $10.9M | ||
| Q3 24 | $93.9M | $11.2M | ||
| Q2 24 | $101.2M | $10.5M |
| Q1 26 | $120.0M | — | ||
| Q4 25 | $129.3M | $75.4M | ||
| Q3 25 | $138.3M | $73.3M | ||
| Q2 25 | $147.2M | $77.4M | ||
| Q1 25 | $150.7M | $82.7M | ||
| Q4 24 | $162.8M | $82.7M | ||
| Q3 24 | $167.4M | $82.1M | ||
| Q2 24 | $172.6M | $82.4M |
| Q1 26 | 0.82× | — | ||
| Q4 25 | 0.69× | 0.22× | ||
| Q3 25 | 0.62× | 0.26× | ||
| Q2 25 | 0.54× | 0.22× | ||
| Q1 25 | 0.48× | — | ||
| Q4 24 | 0.43× | — | ||
| Q3 24 | 0.40× | 0.23× | ||
| Q2 24 | 0.37× | 0.24× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-1.7M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-7.1M | $-1.7M | ||
| Q3 25 | $-8.2M | $1.1M | ||
| Q2 25 | $-3.9M | $-1.6M | ||
| Q1 25 | $-13.2M | $1.7M | ||
| Q4 24 | $-6.7M | $1.1M | ||
| Q3 24 | $-7.2M | $3.6M | ||
| Q2 24 | $-5.8M | $-2.6M |
| Q1 26 | — | — | ||
| Q4 25 | $-7.1M | — | ||
| Q3 25 | $-8.3M | — | ||
| Q2 25 | $-4.0M | — | ||
| Q1 25 | $-13.5M | — | ||
| Q4 24 | $-6.8M | — | ||
| Q3 24 | $-7.7M | — | ||
| Q2 24 | $-6.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | -31.4% | — | ||
| Q3 25 | -38.4% | — | ||
| Q2 25 | -16.6% | — | ||
| Q1 25 | -60.0% | — | ||
| Q4 24 | -28.8% | — | ||
| Q3 24 | -37.6% | — | ||
| Q2 24 | -30.0% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 2.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.66× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 5.12× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LUNG
Segment breakdown not available.
MSS
| Perishables | $14.4M | 52% |
| Nonperishables | $13.2M | 48% |
